|
Market Closed -
Bombay S.E.
13:02:36 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1,335.40 INR | +2.33% |
|
+7.52% | +5.06% |
Company Valuation: Dr. Reddy's Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 714,500 | 767,655 | 1,024,969 | 953,168 | 1,044,616 | 1,112,485 | - | - |
| Change | - | 7.44% | 33.52% | -7.01% | 9.59% | 6.5% | - | - |
| Enterprise Value (EV) 1 | 703,980 | 719,330 | 960,383 | 928,633 | 1,011,902 | 1,082,143 | 1,063,230 | 1,036,556 |
| Change | - | 2.18% | 33.51% | -3.31% | 8.97% | 6.94% | -1.75% | -2.51% |
| P/E | 30.4x | 17.1x | 18.4x | 16.9x | 24.4x | 29.9x | 22.8x | 19.3x |
| PBR | 3.76x | 3.33x | 3.63x | 2.86x | 2.78x | 2.73x | 2.48x | 2.24x |
| PEG | - | 0.2x | 0.8x | 13.12x | -1x | -2.3x | 0.7x | 1.1x |
| Capitalization / Revenue | 3.33x | 3.11x | 3.67x | 2.93x | 3.11x | 3.17x | 2.83x | 2.57x |
| EV / Revenue | 3.28x | 2.92x | 3.44x | 2.85x | 3.01x | 3.08x | 2.7x | 2.4x |
| EV / EBITDA | 13.7x | 11.1x | 12.1x | 10.8x | 15.1x | 17.1x | 13.2x | 11.3x |
| EV / EBIT | 20.5x | 13.8x | 14.8x | 13.4x | 21.8x | 25.8x | 18.4x | 15.2x |
| EV / FCF | 52.3x | 15.1x | 33.1x | 49.1x | 30.3x | 30.1x | 32.1x | 23.9x |
| FCF Yield | 1.91% | 6.61% | 3.02% | 2.04% | 3.3% | 3.32% | 3.12% | 4.19% |
| Dividend per Share 2 | 6 | 8 | 8 | 8 | 8 | 7.482 | 8.373 | 9.13 |
| Rate of return | 0.7% | 0.87% | 0.65% | 0.7% | 0.64% | 0.56% | 0.63% | 0.68% |
| EPS 2 | 28.34 | 54.18 | 66.92 | 67.78 | 51.42 | 44.6 | 58.47 | 69.11 |
| Distribution rate | 21.2% | 14.8% | 12% | 11.8% | 15.6% | 16.8% | 14.3% | 13.2% |
| Net sales 1 | 214,391 | 246,697 | 279,164 | 325,535 | 335,933 | 351,357 | 393,731 | 432,374 |
| EBITDA 1 | 51,400 | 64,559 | 79,481 | 86,236 | 67,048 | 63,155 | 80,731 | 92,091 |
| EBIT 1 | 34,277 | 52,057 | 64,781 | 69,178 | 46,443 | 42,019 | 57,699 | 68,088 |
| Net income 1 | 23,568 | 45,073 | 55,779 | 56,544 | 42,850 | 36,922 | 49,286 | 57,985 |
| Net Debt 1 | -10,520 | -48,325 | -64,586 | -24,535 | -32,714 | -30,343 | -49,256 | -75,929 |
| Reference price 2 | 861.08 | 924.30 | 1,231.03 | 1,144.05 | 1,254.65 | 1,335.40 | 1,335.40 | 1,335.40 |
| Nbr of stocks (in thousands) | 829,771 | 830,526 | 832,611 | 833,152 | 832,596 | 833,073 | - | - |
| Announcement Date | 5/19/22 A | 5/10/23 A | 5/7/24 A | 5/9/25 A | 5/12/26 A | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 29.26x | 3.01x | 16.73x | 0.57% | 11.45B | ||
| 37.66x | 13.18x | 27.98x | 0.53% | 1,143B | ||
| 39.33x | 6.61x | 18.6x | 1.99% | 647B | ||
| 37.45x | 8.4x | 17.37x | 2.4% | 506B | ||
| 21.46x | 5.22x | 12.98x | 2.51% | 384B | ||
| 103.38x | 5.8x | 24.86x | 2.4% | 350B | ||
| 21.99x | 5.69x | 13.69x | 2.94% | 293B | ||
| 22.31x | 4.51x | 12.87x | 1.96% | 265B | ||
| 28.42x | 7.28x | 13.03x | 2.25% | 242B | ||
| -45.78x | 7.1x | 27.53x | 2.07% | 197B | ||
| Average | 29.55x | 6.68x | 18.56x | 1.96% | 403.9B | |
| Weighted average by Cap. | 35.25x | 8.34x | 20.47x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DRREDDY Stock
- Valuation Dr. Reddy's Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















